EP Patent

EP2001469A2 — Thiazolidinedione analogues

Assigned to Metabolic Solutions Development Co LLC · Expires 2008-12-17 · 17y expired

What this patent protects

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension.

USPTO Abstract

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension.

Drugs covered by this patent

Caduet (Amlodipine Besylate) · Pfizer Inc.

Patent Metadata

Patent number: EP2001469A2
Jurisdiction: EP
Classification: —
Expires: 2008-12-17
Drug substance claim: No
Drug product claim: No
Assignee: Metabolic Solutions Development Co LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.